Natalizumab

• Description :

  Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  ——

• Molecular Formula :

  ——

• Notes :

  Research use only, not for human use.

• Receptor :

  Α4β1 integrin

• CAS Number :

  189261-10-7